Wuxi Biologics Stock Filter Stocks by Fundamentals
WXIBF Stock | USD 3.63 0.41 12.73% |
Fundamental analysis of WuXi Biologics allows traders to better anticipate movements in WuXi Biologics' stock price by examining its financial health and performance throughout various phases of its business cycle.
WuXi |
Did you try this?
Run Portfolio Holdings Now
Portfolio HoldingsCheck your current holdings and cash postion to detemine if your portfolio needs rebalancing |
All Next | Launch Module |
WuXi Fundamentals
Return On Equity | 0.12 | |||
Return On Asset | 0.0551 | |||
Profit Margin | 0.31 % | |||
Operating Margin | 0.31 % | |||
Current Valuation | 29.3 B | |||
Shares Outstanding | 4.22 B | |||
Shares Owned By Insiders | 14.17 % | |||
Shares Owned By Institutions | 45.95 % | |||
Price To Earning | 107.74 X | |||
Price To Book | 5.92 X | |||
Price To Sales | 2.11 X | |||
Revenue | 10.29 B | |||
Gross Profit | 4.83 B | |||
EBITDA | 4.03 B | |||
Net Income | 3.39 B | |||
Cash And Equivalents | 9.86 B | |||
Cash Per Share | 2.36 X | |||
Total Debt | 640.51 M | |||
Debt To Equity | 0.12 % | |||
Current Ratio | 2.30 X | |||
Book Value Per Share | 8.25 X | |||
Cash Flow From Operations | 3.43 B | |||
Earnings Per Share | 0.14 X | |||
Price To Earnings To Growth | 0.80 X | |||
Number Of Employees | 10.59 K | |||
Beta | 1.09 | |||
Market Capitalization | 34.77 B | |||
Total Asset | 44.03 B | |||
Z Score | 32.4 | |||
Net Asset | 44.03 B |
About WuXi Biologics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze WuXi Biologics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of WuXi Biologics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of WuXi Biologics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
VALE | Vale SA ADR | |
EGY | Vaalco Energy | |
CMCSA | Comcast Corp | |
BTE | Baytex Energy Corp | |
SOXS | Direxion Daily Semiconductor |
Other Information on Investing in WuXi Pink Sheet
WuXi Biologics financial ratios help investors to determine whether WuXi Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WuXi with respect to the benefits of owning WuXi Biologics security.